Clinical & Translational Oncology

Papers
(The median citation count of Clinical & Translational Oncology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas86
SEOM clinical guidelines for the treatment of head and neck cancer (2020)55
Ferroptosis: an iron-dependent cell death form linking metabolism, diseases, immune cell and targeted therapy54
CDK1 promotes the stemness of lung cancer cells through interacting with Sox245
Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials38
Inhibitory effect of polyphenols (phenolic acids, lignans, and stilbenes) on cancer by regulating signal transduction pathways: a review37
Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism36
Targeting GLS1 to cancer therapy through glutamine metabolism36
Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes33
SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)29
Curcumin suppresses tumor growth of gemcitabine-resistant non-small cell lung cancer by regulating lncRNA-MEG3 and PTEN signaling28
SEOM clinical guideline in ovarian cancer (2020)28
MiR-495-3p and miR-143-3p co-target CDK1 to inhibit the development of cervical cancer26
Multidisciplinary consensus on the criteria for fertility preservation in cancer patients26
Complex roles of discoidin domain receptor tyrosine kinases in cancer25
Social support, coping strategies and sociodemographic factors in women with breast cancer25
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for tre24
SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)23
Hyperbaric oxygen and radiation therapy: a review23
SEOM clinical guideline for the management of cutaneous melanoma (2020)22
SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)22
Trends of incidence, mortality and survival of multiple myeloma in Spain. A twenty-three-year population-based study21
Incidence of venous thromboembolic events in cancer patients receiving immunotherapy: a single-institution experience20
UCHL3 promotes aerobic glycolysis of pancreatic cancer through upregulating LDHA expression20
Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation 20
Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy20
Circ_03955 promotes pancreatic cancer tumorigenesis and Warburg effect by targeting the miR-3662/HIF-1α axis19
Human umbilical cord mesenchymal stem cell-derived exosomes carrying hsa-miRNA-128-3p suppress pancreatic ductal cell carcinoma by inhibiting Galectin-319
Multidisciplinary consensus on cancer management during pregnancy19
IFN-γ inhibits ovarian cancer progression via SOCS1/JAK/STAT signaling pathway18
PILE: a candidate prognostic score in cancer patients treated with immunotherapy18
SEOM clinical guidelines for the treatment of malignant pleural mesothelioma (2020)18
Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumours17
Nerve growth factor orchestrates NGAL and matrix metalloproteinases activity to promote colorectal cancer metastasis17
PARP inhibitor niraparib as a radiosensitizer promotes antitumor immunity of radiotherapy in EGFR-mutated non-small cell lung cancer17
Novel combinatorial strategies for boosting the efficacy of immune checkpoint inhibitors in advanced breast cancers17
Identification of a novel cancer microbiome signature for predicting prognosis of human breast cancer patients17
Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus17
Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?16
The TRIM proteins in cancer: from expression to emerging regulatory mechanisms16
Propofol inhibited gastric cancer proliferation via the hsa-miR-328-3p/STAT3 pathway16
A seven-nuclear receptor-based prognostic signature in breast cancer15
Survival outcomes and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma15
Long-term disease outcome and volume-based decision strategy in a large cohort of multiple brain metastases treated with a mono-isocentric linac-based Stereotactic Radiosurgery technique15
The effect of PD-1 expression on tumor-associated macrophage in T cell lymphoma14
COL4A1, negatively regulated by XPD and miR-29a-3p, promotes cell proliferation, migration, invasion and epithelial–mesenchymal transition in liver cancer cells14
Circular RNA circHIPK3 modulates prostate cancer progression via targeting miR-448/MTDH signaling14
SEOM clinical guidelines for anaemia treatment in cancer patients (2020)14
DDAB cationic lipid-mPEG, PCL copolymer hybrid nano-carrier synthesis and application for delivery of siRNA targeting IGF-1R into breast cancer cells14
Cancer cell-intrinsic STING is associated with CD8 + T-cell infiltration and might serve as a potential immunotherapeutic target in hepatocellular carcinoma13
The role of brachytherapy (interventional radiotherapy) for primary and/or recurrent vulvar cancer: a Gemelli Vul.Can multidisciplinary team systematic review13
Systematic review and meta-analysis efficacy and safety of immune checkpoint inhibitors in advanced melanoma patients with anti-PD-1 progression: a systematic review and meta-analysis13
Physio-pathological effects of m6A modification and its potential contribution to melanoma13
Study on effects of miR-141-3p in proliferation, migration, invasion and apoptosis of colon cancer cells by inhibiting Bcl213
Dynamic biomarkers indicate the immunological benefits provided by Ganoderma spore powder in post-operative breast and lung cancer patients13
Tumor immune microenvironment is influenced by frameshift mutations and tumor mutational burden in gastric cancer13
Clinical significance of multi-slice spiral CT, MRI combined with gastric contrast-enhanced ultrasonography in the diagnosis of T staging of gastric cancer13
Exosome-mediated delivery of SCD-1 siRNA promoted the death of anaplastic thyroid carcinoma cells via regulating ROS level12
COPB2: a transport protein with multifaceted roles in cancer development and progression12
In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types12
Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group12
Circulating exosomal miRNAs and cancer early diagnosis12
Upfront pembrolizumab as an effective treatment start in patients with PD-L1 ≥ 50% non-oncogene addicted non-small cell lung cancer and asymptomatic brain metastases: an exploratory analysis11
Medical ozone induces proliferation and migration inhibition through ROS accumulation and PI3K/AKT/NF-κB suppression in human liver cancer cells in vitro11
Lysophosphatidic acid receptor 6 regulated by miR-27a-3p attenuates tumor proliferation in breast cancer11
microRNA-377-3p inhibits osteosarcoma progression by targeting CUL1 and regulating Wnt/β-catenin signaling pathway11
Surface-guided radiation therapy for breast cancer: more precise positioning11
Evaluation of color Doppler ultrasound combined with plasma miR-21 and miR-27a in the diagnosis of breast cancer11
Microbiota and cancer: current understanding and mechanistic implications11
Predictive and prognostic value of total tumor load in sentinel lymph nodes in breast cancer patients after neoadjuvant treatment using one-step nucleic acid amplification: the NEOVATTL study11
CIP2A silencing alleviates doxorubicin resistance in MCF7/ADR cells through activating PP2A and autophagy10
Over-activation of EFTUD2 correlates with tumor propagation and poor survival outcomes in hepatocellular carcinoma10
5-year results of accelerated partial breast irradiation (APBI) with SBRT (stereotactic body radiation therapy) and exactrac adaptive gating (Novalis®) for very early breast cancer patients: was it al10
Peripheral blood T-cell receptor repertoire as a predictor of clinical outcomes in gastrointestinal cancer patients treated with PD-1 inhibitor10
Downregulation of HOXA11 enhances endometrial cancer malignancy and cisplatin resistance via activating PTEN/AKT signaling pathway10
Prognostic value of neutrophil-to-lymphocyte ratio in advanced cancer patients receiving immunotherapy10
Long-term results of a randomized partial irradiation trial compared to whole breast irradiation in the early stage and low-risk breast cancer patients after conservative surgery10
GEIS-SEHOP clinical practice guidelines for the treatment of rhabdomyosarcoma10
The role of radiotherapy for pancreatic malignancies: a population-based analysis of the SEER database9
Sexual, bladder and bowel function following different minimally invasive techniques of radical hysterectomy in patients with early-stage cervical cancer9
Surgical resection of primary tumor in the extremities improves survival for metastatic soft-tissue sarcoma patients: a population-based study of the SEER database9
Investigation on potential biomarkers of hyperprogressive disease (HPD) triggered by immune checkpoint inhibitors (ICIs)9
A new biological triangle in cancer: intestinal microbiota, immune checkpoint inhibitors and antibiotics9
Senescent thyroid tumor cells promote their migration by inducing the polarization of M2-like macrophages9
Sarcoidosis-like reactions in cancer patients treated with immune checkpoint inhibitors: experience in a Spanish hospital9
Adrenal cancer: relevance of different grading systems and subtypes9
Antibody–drug conjugate as targeted therapeutics against hepatocellular carcinoma: preclinical studies and clinical relevance9
Association of TYRP1 with hypoxia and its correlation with patient outcome in uveal melanoma9
PD-1 and PD-L1 gene expressions and their association with Epstein-Barr virus infection in chronic lymphocytic leukemia9
The peri- and intratumoral immune cell infiltrate and PD-L1 status in invasive squamous cell carcinomas of the penis8
Overall survival for early and locally advanced non-small-cell lung cancer from one institution: 2000–20178
Comparative genomic characterization of melanoma of known and unknown primary8
Alterations in regulatory T cells and immune checkpoint molecules in pancreatic cancer patients receiving FOLFIRINOX or gemcitabine plus nab-paclitaxel8
Expressions of PD-L1 and Nectin-4 in urothelial cancer patients treated with pembrolizumab8
Clinical and molecular characteristics of epidermal growth factor receptor exon 20 insertion mutations in non-small-cell lung cancer8
Mutations in chronic myelomonocytic leukemia and their prognostic relevance8
MiR-181a promotes cell proliferation and migration through targeting KLF15 in papillary thyroid cancer8
SEOR SBRT-SG stereotactic body radiation therapy consensus guidelines for non-spine bone metastasis8
Del-1 enhances therapeutic efficacy of bacterial cancer immunotherapy by blocking recruitment of tumor-infiltrating neutrophils8
A systematic review of craniospinal irradiation for leptomeningeal disease: past, present, and future7
Exclusive 3D-brachytherapy as a good option for stage-I inoperable endometrial cancer: a retrospective analysis in the gynaecological cancer GEC-ESTRO Working Group7
Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia7
Impact of miRNAs expression modulation on the methylation status of breast cancer stem cell-related genes7
Biological functions and potential therapeutic applications of huntingtin-associated protein 1: progress and prospects7
Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivati7
Expression and DNA methylation profiles of EZH2-target genes in plasma exosomes and matched primary tumor tissues of the patients with diffuse large B-cell lymphoma7
Distribution of tumor-infiltrating-T-lymphocytes and possible tumor-escape mechanisms avoiding immune cell attack in locally advanced adenocarcinomas of the esophagus7
Circular RNA hsa_circ_0091579 facilitates the Warburg effect and malignancy of hepatocellular carcinoma cells via the miR-624/H3F3B axis7
Understanding the regulation of β-catenin expression and activity in colorectal cancer carcinogenesis: beyond destruction complex6
Mechanisms of primary and acquired resistance to PD-1/PD-L1 blockade and the emerging role of gut microbiome6
HPV16 infection promotes an M2 macrophage phenotype to promote the invasion and metastasis of esophageal squamous cell carcinoma6
The diagnostic value of miR-21 combined with CT in patients with liver cancer6
The role for intra-arterial chemotherapy for refractory retinoblastoma: a systematic review6
SEOM clinical guideline for management of adult medulloblastoma (2020)6
Efficacy of nintedanib plus docetaxel in patients with refractory advanced epidermal growth factor receptor mutant lung adenocarcinoma6
Urologic, lymphedema, pelvic pain and gastrointestinal symptoms increase after radiotherapy in patients with primary uterine tumors: a prospective longitudinal Swedish cohort study6
0.041547060012817